Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 171
Filtrar
1.
J Dent Res ; 92(7): 635-40, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23677649

RESUMEN

Periodontal tissue homeostasis depends on a complex cellular network that conveys cell-cell communication. Gap junctions (GJs), one of the intercellular communication systems, are found between adjacent human periodontal ligament (hPDL) cells; however, the functional GJ coupling between hPDL cells has not yet been elucidated. In this study, we investigated functional gap-junction-mediated intercellular communication in isolated primary hPDL cells. SEM images indicated that the cells were in contact with each other via dendritic processes, and also showed high anti-connexin43 (Cx43) immunoreactivity on these processes. Gap-junctional intercellular communication (GJIC) among hPDL cells was assessed by fluorescence recovery after a photobleaching (FRAP) analysis, which exhibited dye coupling between hPDL cells, and was remarkably down-regulated when the cells were treated with a GJ blocker. Additionally, we examined GJs under hypoxic stress. The fluorescence recovery and expression levels of Cx43 decreased time-dependently under the hypoxic condition. Exposure to GJ inhibitor or hypoxia increased RANKL expression, and decreased OPG expression. This study shows that GJIC is responsible for hPDL cells and that its activity is reduced under hypoxia. This is consistent with the possible role of hPDL cells in regulating the biochemical reactions in response to changes in the hypoxic environment.


Asunto(s)
Comunicación Celular/fisiología , Uniones Comunicantes/fisiología , Ligamento Periodontal/citología , Adolescente , Adulto , Apelina , Técnicas de Cultivo de Célula , Hipoxia de la Célula/efectos de los fármacos , Hipoxia de la Célula/fisiología , Células Cultivadas , Conexina 43/análisis , Deferoxamina/farmacología , Dendritas/ultraestructura , Regulación hacia Abajo , Femenino , Fluoresceínas , Recuperación de Fluorescencia tras Fotoblanqueo , Colorantes Fluorescentes , Uniones Comunicantes/efectos de los fármacos , Uniones Comunicantes/ultraestructura , Ácido Glicirretínico/análogos & derivados , Ácido Glicirretínico/farmacología , Homeostasis/fisiología , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/análisis , Péptidos y Proteínas de Señalización Intercelular/análisis , Masculino , Microscopía Confocal , Microscopía Electrónica de Rastreo , Osteoprotegerina/análisis , Ligamento Periodontal/ultraestructura , Ligando RANK/análisis , Sideróforos/farmacología , Factores de Tiempo , Adulto Joven
2.
J Dent Res ; 91(10): 955-60, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22895512

RESUMEN

Although human deciduous teeth are an ideal source of adult stem cells, no method for identifying deciduous periodontal ligament (D-PDL) stem cells has so far been developed. In the present study, we investigated whether stage-specific embryonic antigen (SSEA)-4 is a marker that could be used to isolate D-PDL stem cells. The isolated D-PDL cells met the minimum criteria for mesenchymal stem cells (MSCs): They showed plastic adherence, specific-surface antigen expression, and multipotent differentiation potential. SSEA-4+ D-PDL cells were detected in vitro and in vivo. A flow cytometric analysis demonstrated that 22.7% of the D-PDL cells were positive for SSEA-4. SSEA-4+ clonal D-PDL cells displayed multilineage differentiation potential: They were able to differentiate into adipocytes, osteoblasts, and chondrocytes in vitro. A clonal assay demonstrated that 61.5% of the SSEA-4+ D-PDL cells had adipogenic, osteogenic, and chondrogenic potential. Our present study demonstrated that SSEA-4+ D-PDL cells are a subset of multipotent stem cells. Hence, SSEA-4 is a specific marker that can be used to identify D-PDL stem cells.


Asunto(s)
Biomarcadores , Células Madre Multipotentes/inmunología , Ligamento Periodontal/citología , Antígenos Embrionarios Específico de Estadio , Diente Primario/citología , Adipogénesis , Células Madre Adultas/inmunología , Diferenciación Celular , Células Cultivadas , Niño , Condrogénesis , Ensayo de Unidades Formadoras de Colonias , Citometría de Flujo , Humanos , Osteogénesis
3.
Eur J Gynaecol Oncol ; 33(6): 648-51, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23327064

RESUMEN

The authors report a case of granulosa cell tumor of the ovary that followed a rare clinical course, where the primary focus did not appear as a mass, and disseminated foci grew in the abdominal cavity. In 2008, a 70-year-old patient, gravida 6 and para 3, was diagnosed with a perihepatic mass, peritoneal dissemination, and an abdominal wall mass as confirmed by computed tomography (CT) scanning. There was no mass lesion in the pelvis. The pathological diagnosis based on the resected mass in the abdominal wall was malignant mesothelioma. During follow-up, abdominal bloating developed from April 2009. CT scans indicated growth of the intraperitoneal lesions. Therefore, the patient received two cycles of combination therapy with cisplatin and pemetrexed. The treatment was discontinued due to lack of efficacy. The intraperitoneal lesions grew but the clinical course was slow and inconsistent with that of malignant mesothelioma. Central pathological review was requested in April 2011, and a granulosa cell tumor was diagnosed. The patient was referred to the department for detailed examination and treatment. The patient underwent incision of the intraperitoneal tumors, simple total hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. The final pathological diagnosis was normal-size adult-type granulosa cell tumor originating from the left ovary. It was a case of granulosa cell tumor without ovarian enlargement where growth of the metastatic foci was the major observation. As complete surgical resection was achieved and no additional therapy was given, the subject was followed on an outpatient basis and no recurrence was identified.


Asunto(s)
Pared Abdominal/patología , Tumor de Células de la Granulosa/patología , Neoplasias Ováricas/patología , Neoplasias Peritoneales/secundario , Anciano , Femenino , Humanos
4.
Phys Rev E Stat Nonlin Soft Matter Phys ; 76(5 Pt 2): 056215, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18233747

RESUMEN

In this study, the propagation of an action potential in a network of excitable elements is studied numerically. The network we consider consists of excitable elements arranged in the shape of a trifurcated structure having three cables. The system has a branch point, a Y junction, at which the three cables are joined. Two types of external stimulations are considered: a single impulsive stimulation at one of the cable terminals, and a pair of stimuli applied to two different terminals. We have found three basic phases depending on the excitability of the elements for a single external stimulus as follows: (1) signal distributor--as the excitability gets higher, the pulse generated by a stimulus splits into two at the branch point, and two pulses are transmitted to the opposite terminals, (2) propagation block--the pulse in the lower excitable chain is blocked at the branch point, and (3) transient propagation--as the excitability is decreased further, we see that the pulse vanishes before reaching the branch point. By the interaction between the pulses that originate from different sources, signal transmission is recovered if the pulses arrive at the branch point nearly synchronously or after a specific delay time. The effects of the repetition of these two types of stimulation are also investigated. Complex spatiotemporal patterns occur due to pulse-pulse interaction and collisions at the branch point. The input-output relationship, which depends crucially on the repetition period and the time lag between the pair of stimuli, is characterized by the stimulus-response ratio and the interspike interval. We also show the effects of noise on the distribution of the interspike interval.

5.
Phys Rev E Stat Nonlin Soft Matter Phys ; 72(5 Pt 2): 056218, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16383738

RESUMEN

We analyze a pair of excitable FitzHugh-Nagumo elements, each of which is coupled repulsively. While the rest state for each element is globally stable for a phase-attractive coupling, various firing patterns, including cyclic and chaotic firing patterns, exist in an phase-repulsive coupling region. Although the rest state becomes linearly unstable via a Hopf bifurcation, periodic solutions associated to the firing patterns is not connected to the Hopf bifurcation. This means that the solution branch emanating from the Hopf bifurcation is subcritical and unstable for any coupling strength. Various types of cyclic firing patterns emerge suddenly through saddle-node bifurcations. The parameter region in which different periodic solutions coexist is also found.

6.
Phys Rev E Stat Nonlin Soft Matter Phys ; 71(3 Pt 2A): 036226, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15903565

RESUMEN

We analyze the effect of additive periodic stimuli in one-dimensional FitzHugh-Nagumo equations in an excitable regime. With a suitable stimulus interval, the suppression of the pulse propagation occurs in some parameter regime. This propagation failure comes from the formation of the "death spot" where successive pulses annihilate. In the parameter regime where the solitary pulse cannot propagate in space stably, however, periodic stimuli cause a propagation of envelope of a traveling pulse under a "resonance" condition, i.e., the pulse at the leading edge disappears successively, however, an envelope is formed and propagates with keeping its shape.

7.
Neuroscience ; 125(4): 973-80, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15120857

RESUMEN

Adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP) are multi-functional peptides derived from the same precursor, proadrenomedullin. We have studied the regulatory mechanism of expression of these peptides during neuronal differentiation of rat pheochromocytoma PC12 cells by nerve growth factor (NGF). The cellular levels of the peptides increased slightly, and then progressively decreased below the control by NGF. Immunoreactive (ir)-AM in the medium was transiently increased by NGF. Cytochemical staining showed that ir-AM and ir-PAMP were abundantly present in cytoplasm in the undifferentiated cells, and were decreased during culture with NGF. There was no preferential localization of ir-AM or ir-PAMP in neurites in comparison with in cytoplasm in the differentiated cells. Northern blot analysis showed that mRNA encoding these peptides, as detected as a band of 1.6 kb, increased more than three-fold at 1 h after the addition of NGF and then progressively decreased to one fifth of the control during 72 h. Degradation rate of the mRNA was slowed by NGF even when mRNA level is decreased after 72 h of NGF treatment. The transcription rate of their gene increased transiently and then decreased by the long-term treatment with NGF. These results demonstrate that expression of AM and PAMP is regulated by NGF along with time-dependent differentiation: AM gene transcription is transiently activated by NGF, whereas it was suppressed during neuronal differentiation of the cells.


Asunto(s)
Factor de Crecimiento Nervioso/farmacología , Neuronas/efectos de los fármacos , Péptidos/metabolismo , Biosíntesis de Proteínas , Precursores de Proteínas/biosíntesis , Adrenomedulina , Animales , Northern Blotting , Diferenciación Celular/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Neuronas/citología , Neuronas/metabolismo , Células PC12 , Biosíntesis de Péptidos/efectos de los fármacos , Fragmentos de Péptidos/biosíntesis , Fragmentos de Péptidos/efectos de los fármacos , Péptidos/efectos de los fármacos , Feocromocitoma/metabolismo , Precursores de Proteínas/efectos de los fármacos , Proteínas/efectos de los fármacos , ARN Mensajero/análisis , Radioinmunoensayo , Ratas , Factores de Tiempo , Transcripción Genética/efectos de los fármacos
8.
Cell Death Differ ; 10(6): 698-708, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12761578

RESUMEN

The aberrant splicing isoform (PS2V), generated by exon 5 skipping of the Presenilin-2 (PS2) gene transcript, is a diagnostic feature of sporadic Alzheimer's disease (AD). We found PS2V is hypoxia-inducible in human neuroblastoma SK-N-SH cells. We purified a responsible trans-acting factor based on its binding to an exon 5 fragment. The factor was identified as the high mobility group A1a protein (HMGA1a; formerly HMG-I). HMGA1a bound to a specific sequence on exon 5, located upstream of the 5' splice site. HMGA1a expression was induced by hypoxia and the protein was accumulated in the nuclear speckles with the endogenous splicing factor SC35. Overexpression of HMGA1a generated PS2V, but PS2V was repressed by cotransfection with the U1 snRNP 70K protein that has a strong affinity to HMGA1a. HMGA1a could interfere with U1 snRNP binding to the 5' splice site and caused exon 5 skipping. HMGA1a levels were significantly increased in the brain tissue from sporadic AD patients. We propose a novel mechanism of sporadic AD that involves HMGA1a-induced aberrant splicing of PS2 pre-mRNA in the absence of any mutations.


Asunto(s)
Empalme Alternativo/genética , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Proteína HMGA1a/metabolismo , Proteínas de la Membrana/genética , Precursores del ARN/genética , Secuencia de Bases/genética , Sitios de Unión/genética , Exones/genética , Genes Reguladores/genética , Proteína HMGA1a/genética , Humanos , Hipoxia/genética , Hipoxia/metabolismo , Proteínas de la Membrana/biosíntesis , Mutación/genética , Presenilina-2 , Isoformas de Proteínas/biosíntesis , Isoformas de Proteínas/genética , Sitios de Empalme de ARN/genética , ARN Nuclear Pequeño/genética
9.
J Neuroendocrinol ; 14(4): 283-93, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11963825

RESUMEN

Adrenomedullin is a peptide hormone with multifunctional biological properties. Its most characteristic effects are the regulation of circulation and the control of fluid and electrolyte homeostasis through peripheral and central nervous system actions. Although adrenomedullin is a vasodilator of cerebral vasculature, and it may be implicated in the pathomechanism of cerebrovascular diseases, the source of adrenomedullin in the cerebral circulation has not been investigated thus far. We measured the secretion of adrenomedullin by radioimmunoassay and detected adrenomedullin mRNA expression by Northern blot analysis in primary cultures of rat cerebral endothelial cells (RCECs), pericytes and astrocytes. We also investigated the expression of specific adrenomedullin receptor components by reverse transcriptase-polymerase chain reaction and intracellular cAMP concentrations in RCECs and pericytes. RCECs had approximately one magnitude higher adrenomedullin production (135 +/- 13 fmol/10(5) cells per 12 h; mean +/- SD, n = 10) compared to that previously reported for other cell types. RCECs secreted adrenomedullin mostly at their luminal cell membrane. Adrenomedullin production was not increased by thrombin, lipopolysaccharide or cytokines, which are known inducers of adrenomedullin release in peripheral endothelial cells, although it was stimulated by astrocyte-derived factors. Pericytes had moderate, while astrocytes had very low basal adrenomedullin secretion. In vivo experiments showed that adrenomedullin plasma concentration in the jugular vein of rats was approximately 50% higher than that in the carotid artery or in the vena cava. Both RCECs and pericytes, which are potential targets of adrenomedullin in cerebral microcirculation, expressed adrenomedullin receptor components, and exhibited a dose-dependent increase in intracellular cAMP concentrations after exogenous adrenomedullin administration. Antisense oligonucleotide treatment significantly reduced adrenomedullin production by RCECs and tended to decrease intraendothelial cAMP concentrations. These findings may suggest an important autocrine and paracrine role for adrenomedullin in the regulation of cerebral circulation and blood-brain barrier functions. Cerebral endothelial cells are a potential source of adrenomedullin in the central nervous system, where adrenomedullin can also be involved in the regulation of neuroendocrine functions.


Asunto(s)
Barrera Hematoencefálica/fisiología , Encéfalo/citología , Endotelio/citología , Endotelio/metabolismo , Péptidos/genética , Adrenomedulina , Animales , Encéfalo/irrigación sanguínea , Encéfalo/metabolismo , AMP Cíclico/metabolismo , Expresión Génica , Oligonucleótidos Antisentido/farmacología , Péptidos/sangre , Pericitos/metabolismo , ARN Mensajero/análisis , Radioinmunoensayo , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
10.
Neuroreport ; 12(18): 4139-42, 2001 Dec 21.
Artículo en Inglés | MEDLINE | ID: mdl-11742253

RESUMEN

Adrenomedullin (AM) is an important vasodilator in cerebral circulation, and cerebral endothelial cells are a major source of AM. This in vitro study aimed to determine the AM-induced changes in blood-brain barrier (BBB) functions. AM administration increased, whereas AM antisense oligonucleotide treatment decreased transendothelial electrical resistance. AM incubation decreased BBB permeability for sodium fluorescein (mol. wt 376 Da) but not for Evan's blue albumin (mol. wt 67 kDa), and it also attenuated fluid-phase endocytosis. AM treatment resulted in functional activation of P-glycoprotein efflux pump in vitro. Our results indicate that AM as an autocrine mediator plays an important role in the regulation of BBB properties of the cerebral endothelial cells.


Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Fragmentos de Péptidos/farmacología , Péptidos/metabolismo , Vasodilatadores/farmacología , Adrenomedulina , Albúminas/farmacocinética , Animales , Comunicación Autocrina/fisiología , Barrera Hematoencefálica/fisiología , Colorantes/farmacocinética , Impedancia Eléctrica , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Azul de Evans/farmacocinética , Colorantes Fluorescentes/farmacocinética , Técnicas In Vitro , Ratas , Ratas Wistar , Rodamina 123/farmacocinética
11.
Brain Res Mol Brain Res ; 97(1): 59-69, 2001 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-11744163

RESUMEN

The actions and the presence of adrenomedullin (AM) were investigated in cultured human oligodendroglial cell line KG1C. AM and AM mRNA were detected in KG1C cells by immunohistochemistry and RT-PCR. mRNAs for calcitonin receptor-like receptor (CRLR) and receptor-activity-modifying proteins (RAMPs) 1, 2 and 3 but not for calcitonin receptors were detected in the cells, while mRNAs for CRLR, calcitonin receptors and all RAMPs were detected in the human cerebellum. Application of AM resulted in time- and concentration-dependent increases in the cAMP level of KG1C cells. Calcitonin gene-related peptide (CGRP) and amylin, peptides structurally related to AM, also increased cAMP. The potencies for the cAMP production of the three peptides were CGRP > or =AM >> amylin with EC(50) of 8, 18, 90 nM, respectively. The responses induced by AM were strongly inhibited by the CGRP(1) receptor antagonist human CGRP(8-37), and inhibited also by the AM receptor antagonist human AM(22-52). In contrast, the responses induced by CGRP or amylin were inhibited only by CGRP(8-37) and not by AM(22-52). The responses induced by all three peptides were unaffected by the amylin receptor antagonist human amylin(8-37). The CGRP(2) receptor agonist human [Cys(Acm)(2,7)]CGRP significantly increased the cAMP level but the increase was smaller than that caused by CGRP. This increase in cAMP was unaffected by CGRP(8-37), AM(22-52) or by amylin(8-37). These results suggest that in KG1C cells, AM increases cAMP through AM and CGRP(1) receptors, whereas CGRP does so through CGRP(1) and CGRP(2) receptors, and amylin exerts its effects through CGRP(1) receptors. Collectively, these findings imply that AM released from oligodendroglial cells may play a role in the regulation of oligodendrocytes via autocrine/paracrine through AM receptors and CGRP(1) receptors.


Asunto(s)
Amiloide/fisiología , Péptido Relacionado con Gen de Calcitonina/fisiología , AMP Cíclico/biosíntesis , Regulación de la Expresión Génica/efectos de los fármacos , Proteínas del Tejido Nervioso/biosíntesis , Oligodendroglía/metabolismo , Péptidos/fisiología , Sistemas de Mensajero Secundario/efectos de los fármacos , Médula Suprarrenal/citología , Adrenomedulina , Amiloide/farmacología , Animales , Comunicación Autocrina , Neoplasias Encefálicas/patología , Péptido Relacionado con Gen de Calcitonina/farmacología , Proteína Similar al Receptor de Calcitonina , Bovinos , Células Cultivadas , Glioma/patología , Humanos , Péptidos y Proteínas de Señalización Intracelular , Polipéptido Amiloide de los Islotes Pancreáticos , Proteínas de la Membrana/biosíntesis , Proteínas de la Membrana/genética , Proteínas del Tejido Nervioso/genética , Comunicación Paracrina , Fragmentos de Péptidos/farmacología , Péptidos/antagonistas & inhibidores , Péptidos/farmacología , Proteínas Modificadoras de la Actividad de Receptores , Receptores de Calcitonina/biosíntesis , Receptores de Calcitonina/genética , Receptores de Péptido Relacionado con el Gen de Calcitonina/efectos de los fármacos , Receptores de Polipéptido Amiloide de Islotes Pancreáticos , Receptores de Péptidos/antagonistas & inhibidores , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales Cultivadas/efectos de los fármacos
12.
Plant Foods Hum Nutr ; 56(4): 349-58, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11678440

RESUMEN

The effect of dietary hesperetin on the hepatic lipid content and the enzyme activities involved in triacylglycerol (TG) synthesis in rats fed diets with or without 1% orotic acid (OA) was studied. Hepatic TG content was raised by approximately 5-fold after administration of OA for 10 days. The OA-feeding significantly increased the activity of hepatic microsomal phosphatidate phosphohydrolase (PAP), which is the rate-limiting enzyme for TG synthesis. Hepatic glucose-6-phosphate dehydrogenase (G6PDH) and malic enzyme activities were also increased. An addition of 1% hesperetin to the OA-supplemented diet resulted in the decrease of the hepatic TG content by 44% and of microsomal PAP activity. Dietary hesperetin alone neither affected liver TG content nor PAP activity significantly. OA-feeding caused an increased liver cholesterol level, whereas simultaneous addition of hesperetin and OA reduced its content to the control level. A slight reduction of hepatic cholesterol by hesperetin was also observed in the OA-free dietary group. The present study demonstrated that dietary hesperetin can reduce the hepatic TG accumulation induced by OA, and this was associated with the reduced activity of TG synthetic enzyme, PAP.


Asunto(s)
Flavonoides/farmacología , Hesperidina , Hígado/efectos de los fármacos , Hígado/metabolismo , Ácido Orótico/administración & dosificación , Fosfatidato Fosfatasa/metabolismo , Triglicéridos/metabolismo , Animales , Colesterol/sangre , Colesterol/metabolismo , Dieta , Ácidos Grasos/metabolismo , Flavonoides/administración & dosificación , Glucosafosfato Deshidrogenasa/metabolismo , Malato Deshidrogenasa/metabolismo , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Ratas , Ratas Sprague-Dawley , Triglicéridos/sangre
13.
Hear Res ; 158(1-2): 51-6, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11506936

RESUMEN

The middle ear cavity is an air-filled space that must be maintained for effective sound transmission to the inner ear. To examine the mechanisms of water homeostasis in the middle ear, we investigated whether aquaporins (AQPs), a family of water-permeable channels, were expressed in the middle ear. Reverse transcription-polymerase chain reaction and immunoblot analyses revealed that mRNAs encoding AQP1, 4 and 5 (but not 2 or 3) subtypes were expressed in rat middle ear epithelium; AQP1, 4 and 5 were detected as 28-, 30- and 30-kDa proteins, respectively. Immunohistochemical analysis showed that AQP1 was localized at capillary endothelial cells and fibroblasts in lamina propria mucosae; AQP4 was present solely at the basolateral membrane of ciliated cells, whereas AQP5 was on the apical surface of ciliated cells as well as of flat and columnar epithelial cells. The characteristic different localizations of AQP1, 4 and 5 subtypes in the middle ear suggest that middle ear water homeostasis requires the coordinated operation of these AQPs.


Asunto(s)
Acuaporinas/metabolismo , Oído Medio/metabolismo , Proteínas de la Membrana , Animales , Acuaporina 1 , Acuaporina 4 , Acuaporina 5 , Epitelio/metabolismo , Immunoblotting , Inmunohistoquímica , Masculino , Ratas , Ratas Sprague-Dawley
14.
Alcohol ; 24(2): 87-93, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11522428

RESUMEN

Nicotine induces craving, but the degree of craving is believed to be milder than that with other abused drugs. In this article, the neurobiological mechanisms of craving for nicotine and other drugs are reviewed, focusing especially on three factors that can be involved in the development of craving. The first factor is the affective symptoms of withdrawal, the neural basis of which may involve neuroadaptations (desensitization) within the reward systems. Affective symptoms experienced during withdrawal from nicotine are milder than those experienced in withdrawal from other drugs, probably because of its mode of action on the reward systems, which is similar to that of natural rewards. The second factor is the conditioning process, in which environmental stimuli can gain properties of a secondary reinforcer. Nicotine has weak but reliable conditioning effects, and the brain region mediating those effects of nicotine involves the ventral tegmental area. The third factor is a cognitive (memory) process, but little is known about this area.


Asunto(s)
Tabaquismo/fisiopatología , Animales , Condicionamiento Psicológico , Ambiente , Humanos , Nicotina/efectos adversos , Recompensa , Síndrome de Abstinencia a Sustancias/fisiopatología
15.
Alcohol ; 24(2): 99-106, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11522430

RESUMEN

The purpose of the present study was to develop a new clinical evaluation form to compare the clinical features of nicotine dependence with those associated with alcohol, methamphetamine, and inhalant dependence. The clinical evaluation form consisted of six scoring items: subjective effects, tolerance, liking (of drug), social disturbance, withdrawal syndrome, and acute psychic and acute physical disorders. A preliminary clinical investigation was performed to test the validity of the evaluation form. Study subjects were those showing dependence on nicotine (n = 25), alcohol (n = 36), methamphetamine (n = 11), and inhalants (n = 6). All subjects met the Diagnostic and Statistical Manual of Mental Disorders (4th ed.) diagnostic criteria for drug dependence, as defined by the Work Group for the chapter "Substance-Related Disorders": M. A. Schuckit, J. E. Helzer, L. B. Cottler, T. Crowley, P. E. Nathan, & G. E. Woody. Nicotine produced subjective effects, tolerance, liking, and psychic withdrawal symptoms, all of which were mild in degree. However, nicotine did not produce social disturbance, physical withdrawal symptoms, or acute psychic or acute physical disorders. With alcohol, acute psychic and acute physical disorders were prominent, and alcohol also produced a moderate degree of influence on various other items that were evaluated. Methamphetamine produced the most serious acute psychic and acute physical disorders with intensive subjective effects. Inhalants were characterized by an intensive degree of acute psychic disorders and subjective effects with mild withdrawal syndrome. Our study findings revealed that the clinical features of drug dependence could be evaluated by using the new clinical evaluation form. Further study is required to clarify the clinical features of nicotine dependence compared with those of other drugs of dependence.


Asunto(s)
Alcoholismo/fisiopatología , Alcoholismo/psicología , Metanfetamina/efectos adversos , Trastornos Relacionados con Sustancias/fisiopatología , Trastornos Relacionados con Sustancias/psicología , Tabaquismo/fisiopatología , Tabaquismo/psicología , Administración por Inhalación , Adulto , Humanos , Relaciones Interpersonales , Trastornos Mentales/etiología , Métodos , Persona de Mediana Edad , Síndrome de Abstinencia a Sustancias/fisiopatología , Síndrome de Abstinencia a Sustancias/psicología
16.
Biol Pharm Bull ; 24(7): 733-7, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11456109

RESUMEN

A truncated actin with an N-terminus of Met-44 is known to be selectively increased in neutrophils of patients with Behçet's disease and to be generated proteolytically by PMN-elastase (Yamashita S. et al., Biol. Pharm. Bull., 23, 519-522 (2000); Biol. Pharm. Bull., 24, 119-122 (2001)). In this study, the functions of the N-terminal peptide consisting of Asp-2 to Val-43 of beta-actin (42-merP) and the truncated actin with an N-terminus of Met-44 were examined. We first confirmed that the 42-merP existed in the patient plasma. The motility of human peripheral blood neutrophils and neutrophilic granulocytes differentiated from HL-60 cells was suppressed by the 42-merP. Furthermore, when neutrophil-like cells from HL-60 cells were preincubated with 10 nm 42-merP, migration of the cells induced by chemotactic factors such as fMLP and IL-8 was suppressed. The release of PMN-elastase, which is a neutrophil granular enzyme that is responsible for the production of the 42-merP and truncated actin, was suppressed by pretreating the neutrophils with 42-merP before fMLP-stimulation. The truncated actin was unable to polymerize in 0.1 M KCl, suggesting that the increase of truncated actin damages the reconstitution capacity of actin in neutrophils of the patients. These results suggest that the increase of 42-merP and truncated actin in patients with Behçet's disease changes functions of neutrophils


Asunto(s)
Actinas/fisiología , Síndrome de Behçet/metabolismo , Neutrófilos/fisiología , Actinas/genética , Actinas/metabolismo , Sustitución de Aminoácidos , Síndrome de Behçet/genética , Degranulación de la Célula/genética , Movimiento Celular/fisiología , Células Cultivadas , Quimiotaxis de Leucocito/fisiología , Células HL-60 , Humanos , Técnicas In Vitro , Indicadores y Reactivos , Interleucina-8/farmacología , Elastasa de Leucocito/metabolismo , N-Formilmetionina Leucil-Fenilalanina/farmacología , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Fragmentos de Péptidos/fisiología
17.
Nutrition ; 17(5): 385-90, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11377131

RESUMEN

We investigated the efficacy of a 4-wk supplementation of conjugated linoleic acid (CLA) as free fatty acid (FFA) or triacylglycerol (TG) on serum leptin concentration, body-fat accumulation, and mitochondrial beta-oxidation in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. A significant reduction of serum leptin concentration (42%) and a decrease in the wet weights of perirenal, epididymal, and omental/visceral-adipose tissue in TG-CLA and FFA-CLA groups were found in comparison with the OLETF control group. Both forms of CLA supplementation produced a 5.2% decrease in body weight compared with the control even though food intake was similar in the OLETF groups. Moreover, both forms of CLA enhanced carnitine-palmitoyltransferase activity in brown adipose tissue, perirenal adipose tissue, red gastrocnemius muscle, and liver in comparison with the OLETF control group. Serum concentrations of non-esterified fatty acid and TG also were reduced in rats fed diets supplemented with TG-CLA and FFA-CLA.


Asunto(s)
Tejido Adiposo/crecimiento & desarrollo , Ácidos Grasos/metabolismo , Leptina/sangre , Ácido Linoleico/farmacología , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/enzimología , Animales , Peso Corporal/efectos de los fármacos , Carnitina O-Palmitoiltransferasa/metabolismo , Ingestión de Alimentos/efectos de los fármacos , Ácidos Grasos no Esterificados/sangre , Ácido Linoleico/administración & dosificación , Ácido Linoleico/química , Hígado/metabolismo , Masculino , Oxidación-Reducción , Ratas , Ratas Endogámicas OLETF , Resultado del Tratamiento , Triglicéridos/sangre , Aumento de Peso/efectos de los fármacos
18.
Brain Res ; 898(1): 152-7, 2001 Apr 13.
Artículo en Inglés | MEDLINE | ID: mdl-11292458

RESUMEN

Long-term (> or =12 h) treatment of cultured bovine adrenal chromaffin cells with thapsigargin (TG), an inhibitor of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), caused a time (t(1/2)=16.3 h)- and concentration (IC50=37.8 nM)-dependent decrease of cell surface 125I-insulin binding by 35%, but did not change the Kd value. TG caused a sustained increase of cytoplasmic concentration of Ca2+ ([Ca2+]c) in a biphasic manner, and the effect of TG on 125I-insulin binding was abolished by BAPTA-AM. Western blot analysis showed that TG lowered insulin receptor (IR) beta-subunit level in membrane, but did not alter total cellular levels of IR precursor and IR beta-subunit. Internalization of cell surface IR, as measured by using brefeldin A, an inhibitor of vesicular exit from the trans-Golgi network (TGN), was not changed by TG. These results suggest that inhibition of SERCA by TG and the subsequent increase of [Ca2+]c down-regulates cell surface IR by retarding externalization of IR from the TGN.


Asunto(s)
Glándulas Suprarrenales/metabolismo , ATPasas Transportadoras de Calcio/antagonistas & inhibidores , Células Cromafines/metabolismo , Inhibidores Enzimáticos/farmacología , Receptor de Insulina/metabolismo , Retículo Sarcoplasmático/enzimología , Tapsigargina/farmacología , Glándulas Suprarrenales/citología , Animales , Brefeldino A/farmacología , Calcio/metabolismo , Bovinos , Membrana Celular/metabolismo , Células Cultivadas , Quelantes/farmacología , Citoplasma/metabolismo , Regulación hacia Abajo , Ácido Egtácico/análogos & derivados , Ácido Egtácico/farmacología , Insulina/metabolismo , Concentración Osmolar , Factores de Tiempo
19.
J Pharmacol Exp Ther ; 297(2): 657-65, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11303055

RESUMEN

Treatment of cultured bovine adrenal chromaffin cells with cyclosporin A (CsA) increased cell surface [(3)H]saxitoxin ([(3)H]STX) binding by 56% in a time (t(1/2) = 15.2 h)- and concentration (EC(50) = 2.9 microM)-dependent manner but did not change the K(d) value. In CsA-treated cells, veratridine-induced (22)Na(+) influx was augmented with no change in the EC(50) of veratridine; also, alpha- and beta-scorpion venom and Ptychodiscus brevis toxin-3 enhanced veratridine-induced (22)Na(+) influx in a more than additive manner, as in nontreated cells. CsA treatment for 1 to 24 h inhibited calcineurin activity, measured by the in vitro assay, with the IC(50) of 0.6 microM but did not alter cellular level of calcineurin. FK506 or rapamycin elevated [(3)H]STX binding by 36 or 25%, whereas GPI-1046, an immunophilin ligand incapable to inhibit calcineurin, or okadaic acid, an inhibitor of protein phosphatases 1 and 2A, had no increasing effect. The rise of [(3)H]STX binding by CsA was attenuated by the coincident treatment with brefeldin A (BFA), an inhibitor of vesicular exit from the trans-Golgi network. The internalization rate of cell surface Na(+) channels, as determined in the presence of BFA, was decreased in CsA (but not rapamycin)-treated cells (t(1/2) = 20.3 h), compared with nontreated cells (t(1/2) = 13.7 h). CsA treatment, however, did not elevate cellular levels of Na(+) channel alpha-subunit and Na(+) channel alpha- and beta(1)-subunit mRNAs. In CsA-treated cells, veratridine-induced (45)Ca(2+) influx via voltage-dependent Ca(2+) channels and catecholamine secretion were enhanced, whereas high K(+)-induced (45)Ca(+) influx was not. Thus, the inhibition of calcineurin or rapamycin-binding protein causes up-regulation of cell surface functional Na(+) channels via modulating externalization and internalization of Na(+) channels, thus enhancing Ca(2+) channel gating and catecholamine secretion.


Asunto(s)
Glándulas Suprarrenales/metabolismo , Células Cromafines/efectos de los fármacos , Ciclosporina/farmacología , Inmunosupresores/farmacología , Oxocinas , Sirolimus/farmacología , Canales de Sodio/efectos de los fármacos , Tacrolimus/farmacología , Glándulas Suprarrenales/citología , Glándulas Suprarrenales/efectos de los fármacos , Animales , Northern Blotting , Calcineurina/metabolismo , Calcio/metabolismo , Catecolaminas/metabolismo , Bovinos , Células Cultivadas , Immunoblotting , Toxinas Marinas/farmacología , Bloqueantes Neuromusculares/farmacología , Venenos de Escorpión/farmacología , Sodio/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Veratridina/farmacología
20.
Brain Res Mol Brain Res ; 87(2): 175-83, 2001 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-11245919

RESUMEN

We studied whether a novel proadrenomedullin derived peptide was present and what was its physiological function in cultured bovine adrenal chromaffin cells. We found a high level of proadrenomedullin N-terminal 12 peptide (PAMP-12) which consists of a peptide from 9th amino acid to 20th amino acid of proadrenomedullin N-terminal 20 peptide (PAMP-20). PAMP-12 was released from the cells along with catecholamine upon stimulation of nicotinic cholinergic receptors. When PAMP-12 was added in the incubation medium, this peptide inhibited nicotinic receptor-mediated catecholamine release and influx of Na(+) and Ca(2+) into the cells. PAMP-12 did not affect catecholamine release evoked by histamine or by depolarization by high concentration of potassium. PAMP-12 also inhibited synthesis of catecholamines as well as the activation of tyrosine hydroxylase by nicotinic stimulation. Thus, PAMP-12 is an endogenous peptide that regulates release and synthesis of catecholamines by acting on nicotinic cholinergic receptors in an autocrine manner in adrenal chromaffin cells.


Asunto(s)
Células Cromafines/metabolismo , Fragmentos de Péptidos/metabolismo , Péptidos , Proteínas/metabolismo , Receptores Nicotínicos/metabolismo , Médula Suprarrenal/citología , Médula Suprarrenal/metabolismo , Adrenomedulina , Animales , Anticuerpos , Transporte Biológico/efectos de los fármacos , Transporte Biológico/fisiología , Carbacol/farmacología , Radioisótopos de Carbono , Catecolaminas/metabolismo , Bovinos , Agonistas Colinérgicos/farmacología , Células Cromafines/citología , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/farmacología , Proteínas/inmunología , Proteínas/farmacología , Sodio/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...